← Назад к работе
Работы, на которые ссылается эта работа
Работ: 335
Работа: CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
The Mechanism of Double-Strand DNA Break Repair by the Nonhomologous DNA End-Joining Pathway
Обзорная статья2010Цитирований: 2ABIA Protein-Tagging System for Signal Amplification in Gene Expression and Fluorescence Imaging
Marvin E. Tanenbaum, Luke A. Gilbert, Lei S. Qi +2
Статья2014Цитирований: 2ABIIn vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar, Kexian Zhu, Jason Cheng +12
Статья2015Цитирований: 2ABIDJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology
Ricardo Taipa, Conceição Pereira, Inês Reis +4
Статья2016Цитирований: 2ABIDiversity, classification and evolution of CRISPR-Cas systems
Eugene V. Koonin, Kira S. Makarova, Feng Zhang
Обзорная статья2017Цитирований: 2ABIDelivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu, Li Zhang, Hao Liu +1
Обзорная статья2017Цитирований: 2ABIProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Nicole M. Gaudelli, Alexis C. Komor, Holly A. Rees +4
Статья2017Цитирований: 2ABICrossing the blood-brain barrier with nanoparticles
Yiqun Zhou, Zhili Peng, Elif S. Seven +1
Обзорная статья2017Цитирований: 2ABIApplications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Hongyi Li, Yang Yang, Weiqi Hong +3
Обзорная статья2020Цитирований: 2ABINobel Prize 2020 in Chemistry honors CRISPR: a tool for rewriting the code of life
Lukas Westermann, Björn Neubauer, Michael Köttgen
Редакционная статья2020Цитирований: 2ABILipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana +4
Обзорная статья2022Цитирований: 2ABI